PT - JOURNAL ARTICLE AU - Fryer, Helen AU - Peyton-Jones, Meg TI - Should individuals be paid to participate in mass drug administration to control malaria? AID - 10.1101/2022.03.16.22272499 DP - 2022 Jan 01 TA - medRxiv PG - 2022.03.16.22272499 4099 - http://medrxiv.org/content/early/2022/03/18/2022.03.16.22272499.short 4100 - http://medrxiv.org/content/early/2022/03/18/2022.03.16.22272499.full AB - Mass drug administration (MDA) is a malaria control strategy in which antimalarial drugs are offered to a whole community. Although MDA can potentially clear malaria from a community, it is not routinely used in eradication efforts because of ethical concerns and past failures to achieve lasting elimination. One potential means to improving the outcome of MDA is to incentivize individuals to participate, for example, through monetary payments. In this study our aim is to inform the decision to use MDA to eradicate malaria and explore whether individuals should be incentivized to participate. Through the lens of a mathematical model, we clarify how the costs and benefits of MDA are context-dependent. We highlight that in a community experiencing a good improvement in clinical case management – relative to the prevalence of malaria in the community – the addition of MDA can catalyze stable elimination. However, participation rates are critical and individuals who avoid every round of treatment can prevent elimination. We explore how, in this scenario, individual incentives could change the cost-benefit breakdown, measured at three levels – personal, local community and wider community.Competing Interest StatementThe authors have declared no competing interest.Funding StatementProject funded by Oxford Martin School. No payments from a third party were received for any aspect of the submitted workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesTHere are no data in this study